
|Articles|November 29, 2012
Europe clears Picato for actinic keratoses
The European Commission has granted marketing authorization to LEO Pharma for Picato gel, for the treatment of actinic keratosis (AK).
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
KT-621 Produces 98% STAT6 Degradation in AD Patients
2
Transparency Gaps in Prior Authorization Denials and Their Impact on Dermatologic Care
3
AI at the Bedside: How Automated Solutions are Transforming Vitiligo Management
4
Celebrating a Year of Growth and Research
5



















